Upcoming AUS Events

Switch to Calendar View

• Spring 2024 Meeting

  • When
    2024-05-04
  •  
    17:00 - 21:00 (PDT)
  • Location
    750 Republican Street, Building E, Seattle, WA 98109

  Register

  American Uveitis Society Spring 2024 Meeting

  Saturday, May 04, 2024

  Social Hour 5pm to 6pm

  Member Meeting 6pm until concluded

  
  

  University of Washington Karalis Johnson Retina Center (KJRC)

  750 Republican Street

  Building E

  Seattle, WA 98109

  Harnessing the Potential of Ocular Immune Microenvironments:
  From the Front to the Back of the Eye

  The Robert B Nussenblatt MD MPH Memorial Lecture

  will be delivered by

  
  

  Reza Dana MD, MSc MPH

  "Use and Regulation of the Ocular Microenvironment for Improving Corneal Transplant Outcomes"

  and

  
  

  The Ronald E Smith MD Memorial Lecture

  will be delivered by

  Daniel Raphael Saban PhD

  "Reframing Ocular Immunology:

  Physiologic Roles of Immune Cells in the Cornea, Outflow Tract, and Retina"

  
  

  FREE PAPERS

  Free papers will follow the lectures and business meeting.

  
  

  (Abstract submission is now closed.)

  Show details
• UCLA/AUS 2nd International Workshop on Objective Measures of Intraocular Inflammation for Use in Clinical Trials

  • Start
    2024-09-27
  •  
    (PDT)
  • End
    2024-09-28
  •  
    (PDT)
  • Location
    Los Angeles

  The UCLA/AUS 2nd International Workshop on Objective Measures of Intraocular Inflammation for Use in Clinical Trials will provide a 5-year follow-up to the highly successful 2019 AUS UCLA Workshop that focused on how best to obtain objective, reproducible, and clinically relevant data for use as outcome measures in clinical trials dealing with uveitis.  This workshop is again intended for ophthalmologists who participate in clinical research dealing with inflammatory eye diseases (uveitis specialists, retina specialists, pediatric ophthalmologists); clinical trialists; and pharmaceutical and device industry representatives. 

  The goals of the 2024 Workshop are the following:
  

  • To review clinically relevant outcome measures that have been proposed for use in uveitis investigations; how these measures relate to clinical trial design; and the potential techniques for objective quantification of study variables.
  • To review progress toward standardization and validation of those techniques over the 5 years since the 2019 workshop.
  • To discuss plans for future studies that will advance this field further.

  In addition, representatives of the FDA will be invited to comment on regulatory issues relevant to use of devices and incorporation of objective measures into clinical trials.

  
  

  Full agenda, abstract submission, and registration here.

  
  

  Show details